Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast in COVID-19
IRCT20180624040213N2Phase 3Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of montelukast in coronavirus disease 2019 (COVID-19), sponsored by Babol University of Medical Sciences. Started Jul 2020; status: completed.
02
Drugs
montelukast
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20180624040213N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180624040213N2.